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Abstract
Background: Self-efficacy has been determined to be a strong predictor of who will engage in physical activity.
We aimed to evaluate the associations between self-efficacy to perform physical activity, self-reported leisure-time
physical activity and cardiovascular events in a population-based cohort of middle-aged Swedish men with no
previous cardiovascular disease, or treatment with cardiovascular drugs.
Methods: Analyses are based on 377 men randomly selected and stratified for weight and insulin sensitivity from
a population sample of 58-year-old men (n = 1728) and who had answered a question about their competence
to perform exercise (as an assessment of physical self-efficacy). The Saltin-Grimby Physical Activity Level Scale was
used to assess self-reported levels of leisure-time physical activity. Cardiovascular events were recorded during
13-years of follow-up.
Results: The group with poor self-efficacy to perform physical activity had a significantly higher incidence of
cardiovascular events compared with the group with good physical self-efficacy (32.1 % vs 17.1 %, p < 0.01).
Multivariate analyses showed that poor physical self-efficacy was associated with an increased relative risk of 2.0
(95 % CI 1.2 to 3.0), of having a cardiovascular event during follow-up also after adjustments for co-variates such
as waist to hip ratio, heart rate, fasting plasma glucose, serum triglycerides, systolic blood pressure, apoB/apoA-I
ratio and leisure-time physical activity.
Conclusion: Self-efficacy to perform physical activity was strongly and independently associated with cardiovascular
events and was superior to self-assessed physical activity in predicting cardiovascular events during 13-years of
follow-up in a group of middle-aged men, without known CVD or treatment with cardiovascular drugs.
Background
Inactive lifestyles have become a predominant and per-
vasive feature of industrialized nations [1]. Epidemio-
logical studies have shown that physical inactivity
contributes to an early onset of cardiovascular disease
(CVD) [2–6]. Conversely, regular physical activity has
been shown to reduce individual cardiovascular risk
factors, including blood lipids, blood pressure, and
body weight, and to improve glucose metabolism [7, 8].
Accordingly, a recent meta-analysis showed that leisure-
time physical activity reduces the overall risk of CVD
among both men and women [9].
To assess physical activity in large populations, self-
report instruments (questionnaires) are the most prac-
tical and widely used tools. The simple four-level
Saltin-Grimby physical activity level scale (SGPALS), an
instrument for self assessment of physical activity
levels, has been shown to identify physically inactive
individuals with a greater risk of elevated cardiovascular
risk factors, as well as with increased risk of CVD
morbidity and mortality [10, 11].
Although there is a strong consensus on the inverse
relationship between physical activity and CVD, most
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evidence for the beneficial effect of physical activity is
derived from observational studies [8, 12, 13]. It is
therefore possible that these studies suffer from a posi-
tive selection bias and that people who report a high
physical activity represent a healthier selection of the
population who, for whatever reasons, may find it easy
to exercise. Self-efficacy beliefs, as introduced by Bandura
[14], are said to influence not only the courses of action
pursued, but also the effort expended and endurance
when facing difficulties. People with high levels of self-
efficacy are more likely to pursue challenging goals, cope
with pain, and persevere through setbacks, while those
with low self-efficacy avoid challenges and tend to give up
when confronted with obstacles [15]. Thus, poor self-
efficacy regarding being physically active, may reflect a
state of frailty or a less optimistic self-belief about one’s
capability to perform physical activity [16]. While widely
used and practical, self-assessed PA questionnaires has
been shown to relatively poorly assess true PA activity and
studies have shown that participants tend to report more
vigorous and less sedentary time compared with objective
methods [17, 18] and there is a need to identify stronger
predictors than self-assessed PA, with better validity and
stronger associations to outcomes.
However, self-efficacy for physical activity in itself has
not previously been studied as a predictor of cardiovas-
cular events. We hypothesized that self-estimated self-
efficacy for physical activity assessed from a single ques-
tion “How do you assess your competence to perform
various physical activities (such as walking or jogging)” is
associated with future cardiovascular events, even when
adjusted for self-estimated physical activity. Hence, the
aim of the present study was to evaluate the association
between a subjective measure of self-efficacy for phys-
ical activity and cardiovascular events during 13-years




The initial study group comprised 391 men randomly
selected from a total population sample of 58-year-old
men (n = 1728), as part of a previous study [19]. The
sample size was originally calculated as the number of
subjects necessary to include in order to show a significant
difference in the carotid artery intima-media thickness be-
tween those in the first and fifth quintiles of fasting
plasma insulin concentration (α = 0.05 and β = 0.20). The
current study group has been extensively studied before
[20–22], and was stratified to reflect all stages of weight as
well as insulin sensitivity. However, in the present study
14 subjects had missing data on self-efficacy to perform
physical activity and/or leisure-time physical activity, giv-
ing a final study group of 377 subjects with complete data.
The subjects with missing data were not significantly dif-
ferent to the subjects, who had a complete set of data. No
subjects were lost to follow-up.
All subjects were of Swedish ancestry and lived in the
Gothenburg region. Exclusion criteria were CVD, clin-
ical diabetes mellitus (fasting blood glucose ≥ 6.1 mmol/
L (109.8 mg/dl) or medication) or other clinically overt
disease, untreated diastolic blood pressure >100 mmHg,
treatment with cardiovascular drugs (i.e. treatment of
ischemic heart disease, heart failure, hypertension,
hyperlipidaemia, or diabetes mellitus) or unwillingness
to participate. These exclusion criteria were chosen to
minimize the risk that the follow-up results are con-
founded by previous CVD.
The subjects received both written and oral informa-
tion before giving written consent to participate. The
subjects signed a consent form and the researchers saved
the original, signed form and the subject got a copy of it.
The Gothenburg University ethics committee approved
the study (no: 89–95). The ethics committee approved
this consent procedure.
Baseline measurements
The baseline data was collected between 2nd October
1995 and 14th May 1997.
Established questionnaires were used to evaluate the
medical history, including previous and current disease
(s), smoking habits and alcohol consumption [19]. The
total number of smoking years was multiplied by the
number of cigarettes smoked daily and the product was
termed 'cigarette years’ [19].
All examinations and measurements were performed at
the Wallenberg Laboratory for Cardiovascular Research,
Sahlgrenska University Hospital, Gothenburg, Sweden.
Weight and height were measured and body mass
index (BMI) was calculated. Waist circumference was
measured directly on the skin or over a single layer of
light close-fitting clothing at the point between ribs and
the iliac crest. Further, hip circumference was measured
where the buttocks were largest (2–4 in. below the um-
bilicus for men). Waist to hip ratio (WHR) was calcu-
lated by dividing the waist measurement with the hip
measurement. Sagittal abdominal diameter (SAD; the
distance from the back to the upper abdomen, midway
between the top of the pelvis and the bottom of the ribs)
was measured in a supine position with subjects dressed
in underwear. Blood pressure was measured twice after
5 min supine rest and the resting heart rate was recorded
from a 12-lead standard-Electrocardiogram (ECG).
Venous blood samples were drawn after a fasting
period of at least 6 h. Cholesterol and triglyceride levels
were determined by enzymatic techniques (Thermo Fisher
Scientific Oy, Vantaa, Finland). High-density lipoprotein
(HDL)-cholesterol was determined after precipitation of
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apolipoprotein B (apoB)-containing lipoproteins and low-
density lipoprotein (LDL)-cholesterol was calculated as
described by Friedewald et al. [23]
Apolipoproteins (apoA-I and apoB) were measured on
a Konelab 20 Auto-analyzer (Thermo Scientific, Vantaa,
Finland) using a turbidimetric method.
Assessment of physical self-efficacy on the visual
analogue scale
For assessment of self-efficacy to perform physically activ-
ity (henceforth, defined as self-efficacy), we used one ques-
tion from the Minor Symptom Evaluation (MSE) profile
questions: “How do you assess your ability to perform
various physical activities (such as walking or jogging)?”
The MSE questionnaire focuses on minor symptoms
affecting daily living, and the full questionnaire is a 22-
item questionnaire designed to evaluate minor symptoms
experienced from drug treatment [24].
A Visual Analogue Scale (VAS; a straight horizontal line
100 mm in length) was used for estimation of self-efficacy.
The end points are defined in words denoting the extreme
poles of the response to be measured as follows: very easy
(VAS 0), indicating a high self efficacy, and very hard
(VAS 100), indicating a very low self efficacy.
After the subjects had estimated their self-efficacy using
the VAS, they were divided into two groups: those scoring
< 50 mm and those scoring ≥ 50 mm. Scores ≥ 50 mm
were defined as poor physical self-efficacy. This cut-off
was chosen based on a previous study that used a VAS to
evaluate the association between subjective measures of
physical activity and dyslipidaemia; subjects who assessed
their daily activity as active (in this case ≥50 mm) had
lower LDL-cholesterol and triglyceride levels and in-
creased HDL-cholesterol compared with the inactive
group [25]. A receiver operating characteristic (ROC)
curve and the area under the ROC curve (AUC) was used
as a relative measure of test efficiency for events. The
AUC showed to be largest at the suggested cut-off be-
tween < 50 mm and ≥ 50 mm and had an asymptotic sig-
nificance of 0.039.
Assessment of leisure-time physical activity
Self-reported level of leisure-time physical activity was
also determined using the SGPALS, as previously de-
scribed [10, 26]. Although the SGPALS is a four-level
scale, studies have shown that less than 4 % of partici-
pants report the highest activity level [6]. In this study,
only 1 % of the participants reported being physically
active at the highest level. Therefore, for our study ana-
lyses, we merged the two groups with highest activity to
form the vigorous physical activity group. The participants
are thus divided into the following three categories:
1) Sedentary lifestyle (low physical activity): spends
leisure time mostly reading, watching TV or other
sedentary activities
2) Moderate physical activity: walking, cycling or other
mild physical activity such as gardening, fishing or
bowling at least 4 h per week
3) Vigorous physical activity: running, swimming,
tennis, cross-country skiing or other exercise that
leads to sweating several days per week.
The SGPALS has previously been validated against fit-
ness levels, cardiovascular risk factors [10, 27], as well as
long-term cardiovascular morbidity and mortality [11].
In addition, moderate correlations between the SGPALS
and objective accelerometer data, have been reported in
the Malmö Diet and Cancer study [28].
Assessment of physical activity readiness
The study exclusion criteria ensured that all subjects
had no previous cardiac or pulmonary disease or other
clinically overt diseases that could affect their ability to
be physically active. In addition, to account for possible
reverse causations, the number of minor symptoms re-
ported from the subjects on the study questionnaire was
transferred to a Physical Activity Readiness Question-
naire (PAR-Q) and included as a covariate (pass/fail)
[29]. The PAR-Q asks several questions regarding heart
trouble, chest pain, high blood pressure, dizzy spells, joint
problems, and other problems that may prevent subjects
from participating in physical activities. Since the present
cohort was previously healthy, PAR-Q questions 5 and 7
were selected to assess bone or joint problems or other
reasons for not being physically active. A positive response
to any question results in a failure of the PAR-Q.
Follow-up of cardiovascular events
Cardiovascular events during 13 years of follow-up were
defined as cardiovascular death, non-fatal myocardial in-
farction, non-fatal stroke, claudication, angina pectoris,
revascularisation procedures, or hospitalisation for heart
failure (only the first event was counted in each subject).
The events and cause of death were collected by search-
ing the Swedish national inpatient register (IPR) after
contact with the Centre of Epidemiology at the National
Board of Health and Welfare. The IPR has a high exter-
nal and internal validity for CVD [30].
Statistics
All data management and statistical analyses were con-
ducted using PASW Statistics 18 (SPSS Inc.). Descriptive
statistics were used to summarize baseline characteristics
in the total sample and by physical self-efficacy and leis-
ure-time physical activity categories. Comparisons be-
tween groups were performed using the Mann–Whitney
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U or Chi-square-test. Kruskal-Wallis test was used to
analyze the relation between two or more categorical vari-
ables or non-normal distributed variables.
Multi-variable logistic regression analysis was used to
explore the association between risk factors and cardio-
vascular events. The regression analyses were performed
using cardiovascular events as the dependent variable
and adjusting for a number of co-variates in different
models (Table 3). The anthropometric and metabolic
parameters were entered in the form of continuous
variables, the physical self-efficacy, leisure-time physical
activity and PAR parameters were entered as nominal or
ordinal variables. Regression analyses were performed in
three steps. In the first step, the models were adjusted
for anthropometric and metabolic parameters. In the
second step, the models were adjusted for PAR-Q (pass/
fail) in addition to anthropometric and metabolic param-
eters. Finally, in the third and last step, subjects who
failed the PAR-Q (n = 26) were excluded and the models
were adjusted for anthropometric and metabolic param-
eters as in the first step.
Results
Self-efficacy to perform physical activity and level of
leisure-time physical activity
The MSE question concerning self efficacy to perform
physical activity was completed by 377/391 subjects
(96.4 %). The majority of the population (321/377; 85.1 %)
was defined as having a good self-efficacy (VAS <50 mm);
the remaining 56/377 (14.9 %) were defined as having low
self-efficacy (VAS ≥50 mm). Concerning leisure-time
physical activity, 67 % of the population assessed their ac-
tivity as moderate (260/377), 21 % as vigorous (78/377)
and 10 % (39/377) as inactive. Increasing levels of leisure-
time physical activity were associated with good physical
self-efficacy (p < 0.001 for trend; Fig. 1).
Anthropometric, metabolic parameters and education
length in relation to self-efficacy and leisure-time phys-
ical activity are shown in Table 1. Briefly, WHR, heart
rate, fasting plasma glucose and serum triglyceride
levels were higher at baseline in the group with poor
self-efficacy. Furthermore, increasing levels of leisure-
time physical activity were significantly associated with
decreased levels of waist circumference, WHR, SAD,
heart rate, triglycerides, apoB, apoB/apoA-I ratio and
cigarette years.
The number of minor symptoms that may affect phys-
ical activity readiness (as assessed using the PAR-Q) was
significantly higher in the group with poor self-efficacy
compared with the group with good self-efficacy (Table 1).
Cardiovascular events
In the 13-year follow-up, 73 fatal and non-fatal cardio-
vascular events were recorded (Table 2). Of these, the
main events were stroke and myocardial infarction
(Table 2).
There was no difference in the incidence of cardio-
vascular events between the groups who were physically
inactive at leisure time at baseline, and those with
higher levels of leisure-time physical activity (Table 2).
In contrast, the group with poor self-efficacy at baseline
had a significantly higher incidence of cardiovascular
events compared with the group with good self-efficacy
(Table 2).
The group that had a cardiovascular event during follow
up, was observed to have an increased blood pressure and
apoB/apoA-I ratio compared to the group which had no
event (134 ± 19 vs. 128 ± 17, p = 0.009 and 0.94 ± 0.27 vs.
0.86 ± 0.24, p = 0.017, respectively). No other differences
were observed.
Multivariate regression analysis
Self-efficacy to perform physical activity showed to be
an independent and strong (significant) predictor for
cardiovascular events also after adjustment for cardio-
vascular risk factors. Additionally, when the models
were controlled for activity level, according to SGPALS,
self-efficacy remained an independent predictor of CV
events. When excluding the subjects who failed the
PAR-Q from the regression analysis, self-efficacy was
still a strong significant predictor for cardiovascular
events with maintained risk magnitude (Table 3).
Fig. 1 Visual Analogue Scale (VAS) values for physical self-efficacy across
leisure-time physical activity groups. Increasing levels of leisure-time
physical activity were associated with good physical self-efficacy
i.e. lower values on the (VAS) (p < 0.001 for trend
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Discussion
The main finding of the present study of middle-aged
men with no known cardiovascular disease at baseline
was that the incidence of cardiovascular events during
13 years of follow-up was significantly higher in men
with poor self-efficacy for physical activity at baseline,
compared to men with high self-efficacy. Indeed, the
increased risk was significant also after adjustment for
classical cardiovascular risk factors, such as systolic
blood pressure and apoB/apoA-I ratio. In contrast, there
was no significant difference in the incidence of cardiovas-
cular events between the groups when the study subjects
were divided according to their self-reported level of
leisure-time physical activity, at baseline.
Interestingly, in the present study, when both self-
efficacy and leisure-time physical activity were included in
the regression models, only self-efficacy to perform phys-
ical activity was shown to be a significant and independent













Weight (kg) 84.6 ± 15.0 86.8 ± 17.3 84.1 ± 14.5 87.6 ± 16.2 84.5 ± 15.1 83.4 ± 14.1
Waist circumference (cm) 96 ± 12 99 ± 14 96 ± 12 101 ± 13 96 ± 12 93 ± 11*
Waist-hip ratio 0.94 ± 0.07 0.97 ± 0.08* 0.94 ± 0.06 0.97 ± 0.08 0.95 ± 0.06 0.92 ± 0.06***
Sagittal abdominal diameter (cm) 22 ± 4 23 ± 4 22 ± 3 23 ± 4 22 ± 4 20 ± 3*
Blood pressure (mmHg)
Systolic 129 ± 17 132 ± 17 129 ± 17 130 ± 18 130 ± 18 126 ± 13
Diastolic 77 ± 10 77 ± 11 77 ± 10 78 ± 11 77 ± 10 76 ± 8
Heart rate (bpm) 64 ± 10 67 ± 10* 64 ± 10 69 ± 10 64 ± 10 60 ± 8***
Plasma glucose (mmol/L) 5.5 ± 1.3 5.9 ± 2.0* 5.4 ± 1.1 5.9 ± 2.0 5.9 ± 2.0 5.9 ± 2.0
Serum cholesterol (mmol/L)
Total 6.01 ± 1.11 6.20 ± 1.22 5.96 ± 1.07 6.18 ± 1.24 6.02 ± 1.15 5.91 ± 0.85
LDL 4.02 ± 0.93 4.17 ± 1.08 4.02 ± 0.93 4.10 ± 1.01 4.08 ± 1.00 3.94 ± 0.79
HDL 1.27 ± 0.36 1.27 ± 0.41 1.27 ± 0.36 1.20 ± 0.32 1.26 ± 0.36 1.36 ± 0.43
Triglyceridesa 1.32 ± 1.06 1.56 ± 0.95* 1.32 ± 1.06 1.67 ± 1.82 1.36 ± 0.83 1.23 ± 1.19*
Apolipoproteins (g/L)
ApoB 1.20 ± 0.27 1.27 ± 0.29 1.20 ± 0.27 1.27 ± 0.26 1.22 ± 0.29 1.15 ± 0.23*
ApoA-I 1.42 ± 0.22 1.42 ± 0.27 1.42 ± 0.22 1.35 ± 0.20 1.42 ± 0.22 1.46 ± 0.26
ApoB/apoA-I ratio 0.87 ± 0.24 0.93 ± 0.28 0.87 ± 0.24 0.97 ± 0.26 0.88 ± 0.24 0.82 ± 0.25*
Smoking (yes) b n, % 89, 23.6 11, 19.6 78, 24.3 11, 28.2 68, 26.2 10, 12.8f
Cigarette years 333 ± 419 358 ± 391 333 ± 419 499 ± 498 342 ± 412 216 ± 334***
Alcohol intake (g/day) 17.4 ± 15.8 16.0 ± 14.3 17.4 ± 15.8 19.5 ± 16.4 17.1 ± 16.0 15.2 ± 11.3
PARc failure, % 26, 6.9 11, 19.6*** 15, 4.7 4, 10.3 17, 7.0 5, 6.8
Lenght of education (years) 11.8 ± 3.8 12.1 ± 4.0 11.8 ± 3.8 11.4 ± 3.9 11.6 ± 3.7 12.6 ± 4.1
a Geometric mean
b Pearson Chi-square
* <0.05, *** <0.001 compared to VAS <50 mm; * <0.05, *** < 0.001 for trend
Table 2 Cardiovascular events according to physical self-efficacy and leisure-time physical activity
VAS≥ 50 mm (n = 56) VAS < 50 mm (n = 321) Inactive lifestyle (n = 39) Moderate PA (n = 260) Vigorous PA (n = 78)
Myocardial infarction n, (%) 5 (8.9) 13 (4.0) 4 (10.3) 12 (4.6) 2 (2.6)
Stroke n, (%) 7 (12.5) 27 (8.4) 5 (12.8) 22 (8.5) 7 (9.0)
Claudication n, (%) 0 (0) 2 (0.6) 0 (0) 2 (0.8) 0 (0)
Revascularization n, (%) 2 (3.6) 9 (2.8) 1 (3) 5 (1.9) 5 (6.4)
Heart failure n, (%) 4 (7.1) 2 (0.6) 0 (0) 6 (2.3) 0 (0)
Angina n, (%) 0 (0) 2 (0.6) 0 (0) 2 (0.8) 0 (0)
Total n, (%) 18 (32.1) 55 (17.1)** 10 (25.6) 49 (18.8) 14 (17.9)
Pearson Chi-square; ** <0.01
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predictor for cardiovascular events. Although we observed
a co-variation between self-efficacy and leisure-time phys-
ical activity, the correlation was only moderate. The two
variables could hold different information or alternatively
they may both reflect the level of PA although differently.
Efficacy expectations influence the behaviour through a
number of processes. Physical activity is composed of
challenging tasks and efficacy beliefs seem to be important
motivational regulators of this sort of activity [31], and a
study has shown that participants with high self-efficacy
reported significantly greater positive well-being and less
psychological distress and fatigue during exercise and
after, despite exercising at the same level of intensity as
participants with low self-efficacy [32]. Also, studies com-
paring self-reported PA and objectively measured PA have
shown large differences, where subjects overestimate their
PA compared to objectively measured PA, especially with
regard to vigorous intensity and particularly among over-
weight subjects. Respondents in general may experience
difficulty assessing the intensity of an activity and over-
weight subjects may rate an activity as vigorous more eas-
ily than normal weight subjects [17].
Our data differs somewhat from other previous stud-
ies. For example, a meta-analysis with data from 26
studies, including over 510,000 individuals, showed that
a high level of leisure-time physical activity provided
significant protection against coronary heart disease
[33]. In our study, we could not show any association
between leisure-time PA level and cardiovascular events
at follow-up. Although the used scale for assessment of
PA-level, has been shown to discriminate between risk
factors, individual fitness levels and cardiovascular mor-
bidity in earlier studies, self assessment of PA is still infer-
ior, in estimating the true PA-level of the individual, as
compared to more objective assessments of PA, such as
measurement of VO2-max and/or accelerometer data
[34–36]. As a result of the present study, one might
speculate that the subject´s own assessment of his/her
self-efficacy for being physically active may estimate a
more true level of PA of the individual, better than the
PA-level assessed by direct questions.
Not surprisingly, cardiovascular events were associated
with classical risk factors such as blood pressure and
apoB/apoA-I ratio in this cohort, as have been shown in
many previous studies. Observational and interventional
studies have shown that blood pressure levels are strongly
and directly related to the relative risks of stroke and heart
disease [37]. Furthermore, both the INTERHEART and
the INTERSTROKE studies showed apoB/apoA-I ratio is
a strong predictive variable for myocardial infarction as
well as stroke [38, 39].
If self-efficacy for physical activity reflects the level of
PA of the patient, we would expect an association with
self-efficacy to different cardiovascular markers, by which
PA traditionally conveys its positive effects on CVD.
However, no uni-variate association between self-efficacy,
blood pressure and apoB/apoA-I ratio, was observed in
the present study. In contrast, poor self-efficacy was asso-
ciated with unfavourable alterations in metabolic variables
such as increased WHR, increased fasting plasma glucose
and serum triglyceride levels.
An interesting alternative explanation is that self effi-
cacy to perform physical activity, may instead be a
proxy for identifying a selection of individuals having
other advantages, potentially making them less likely to
develop CVD. This may be a genetic predisposition, a
positive mental state or the effect of previous environmen-
tal exposure that coincides or results in a lower risk for
Table 3 Multivariate regression analysis with cardiovascular events as dependent variable
Step 1 (n = 377) Step 2 (n = 377) Step 3 (n = 351)
Model Variables included Risk Ratio 95 % CI p-value Risk Ratio 95 % CI p-value Risk ratio 95 % CI p-value
1 Physical self-efficacy 1.9 1.2 to 2.8 0.010 1.9 1.2 to 2.8 0.012 1.9 1.2 to 2.9 0.011
2 Physical self-efficacy +WHR, heart rate, fasting
plasma glucose, serum triglycerides
1.9 1.2 to 2.8 0.015 1.9 1.2 to 2.8 0.016 1.9 1.2 to 3.0 0.016
3 Physical self-efficacy +WHR, heart rate, fasting
plasma glucose, serum triglycerides + leisure-
time PA
1.9 1.2 to 2.9 0.014 1.9 1.2 to 3.0 0.015 2.0 1.2 to 3.1 0.018
4 Physical self-efficacy + SPB and apoB/apoA-I
ratio
1.9 1.9 to 2.9 0.014 1.9 1.2 to 2.9 0.014 2.0 1.2 to 3.0 0.010
5 Physical self-efficacy + SPB and apoB/apoA-I
ratio + leisure-time PA
1.9 1.2 to 2.9 0.014 1.9 1.2 to 3.2 0.015 2.0 1.2 to 3.1 0.015
6 Physical self-efficacy +WHR, heart rate, fasting
plasma glucose, serum triglycerides, SPB,
apoB/apoA-I ratio and leisure-time PA
2.0 1.2 to 3.0 0.010 2.0 1.2 to 3.1 0.010 2.1 1.2 to 3.2 0.010
CI, Confidence interval
Step 1- the models are adjusted for anthropometric and metabolic parameters; Step2- the models are adjusted for PAR-Q (pass/fail) and for anthropometric and
metabolic parameters; Step 3- subjects who failed the PAR-Q were excluded (n = 26) and the models were adjusted for anthropometric and metabolic parameters
as in Step 1
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CVD. It may even be that self-efficacy for physical activity
is an individual positive quality that has a stronger predict-
ive value for cardiovascular disease than individual activity
level in itself. The findings of the present study may have
important clinical implications. Indeed, it is tantalising to
speculate that a single question reflecting self-efficacy may
be a clinical instrument for risk prediction.
Importantly, we found a difference in physical readi-
ness between the groups that reported poor versus good
self-efficacy. However, when responses to the PAR-Q
were included as a covariate in the multivariate models,
the results were unchanged. Furthermore, when the
subjects who failed the PAR-Q were excluded from the
cohort and the multivariate models were adjusted for
anthropometric and metabolic parameters and leisure-
time physical activity, the association between self-efficacy
and cardiovascular events was still maintained.
There are some limitations to the present study that
need to be addressed. VAS provides a subjective rather
than objective measure of the clinical phenomenon and
is thus subject to potentially higher error rates [25].
Further, the MSE question used for assessing self-efficacy
cannot distinguish if a subject has different self-efficacy
for different activities (e.g. would they be happy to run but
not to cycle?). This should be addressed in future studies.
Another limitation of the study is external validity, i.e. that
this cohort only included men of Swedish ancestry within
a limited age category, and the results found in the present
study may not be extended to other age groups, women
or other ethnicity groups. The reason that we could not
observe a difference between leisure-time physical activity
levels and cardiovascular events in the present study could
be due to not having sufficient power. A further limitation
is that medical data concerning depression was not avail-
able in this study and low-self-efficacy expectancies are an
important feature of depression [14], this may have af-
fected physical self-efficacy. However, all subjects were
clinically healthy eliminating sever forms of depression.
Nevertheless, one strength of our study is that we inves-
tigate a well-characterized cohort of men of the same age
of Swedish ancestry, living in the Gothenburg area, which
controls for variation in age, sex and ethnicity. Further,
the included subjects were initially free of CVD, clinical
diabetes mellitus or other clinically overt disease, treat-
ment with cardiovascular drugs, such as treatment of
ischemic heart disease, heart failure, hypertension,
hyperlipidaemia, diabetes mellitus, which might other-
wise have confounded the interpretation of results.
Conclusion
In summary, we showed that self-efficacy to perform
various physical activities, such as walking or jogging, self-
assessed using a VAS, was strongly and independently
associated with cardiovascular events during 13-years of
follow-up in a group of middle-aged men without a his-
tory of CVD or diabetes and who were not taking cardio-
vascular drugs. Furthermore, we showed that subjectively
judged poor self-efficacy was superior to self-assessed
physical activity in predicting cardiovascular events. Self-
efficacy to perform physical activity may be a better pre-
dictor of CVD events, partly by better assessing the true
level of PA of the individual, and possibly by identifying
other, as yet unknown, risk factors. It remains, however, to
be investigated whether a single question assessed on a
VAS can be used as a rapid screening tool for the predic-
tion of future cardiovascular events in the clinical setting.
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